Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
GV1001治疗已接受多奈哌齐治疗的中重度阿尔茨海默病患者的疗效和安全性：一项II期随机、双盲、安慰剂对照、多中心临床试验
期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-021-00803-w
Koh, Seong-Ho; Kwon, Hyuk Sung; Choi, Seong Hye; Jeong, Jee Hyang; Na, Hae Ri; Lee, Chan Nyoung; Yang, YoungSoon; Lee, Ae Young; Lee, Jae-Hong; Park, Kyung Won; Han, Hyun Jeong; Kim, Byeong C; Park, Jin Se; Lee, Jee-Young; Kim, Sangjae; Lee, Kyu-Yong
